More localized bands of squalls were expected to form, with up to two feet of snow possible in some areas, according to Canada’s forecast agency. By Adeel Hassan Severe weather warnings were in effect ...

CHONGQING, CHINA - SEPTEMBER 10: In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. The maker of Wegovy and Ozempic, ...

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit weight-loss drugs didn't slow the progress of Alzheimer's disease. Novo ...

CHICAGO (Reuters) -Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and Wegovy, but scientists are still ...

The Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM) sits squarely at the center of Monday's shock. The fund's top weights — Eli Lilly at 18.72% and Novo Nordisk at 13.23% — mean that more than ...

Novo has experienced a prolonged sell.off over the last months, declining more than 65% from all-time highs. Why some kind of pessimism is justified, the current market cap is way to low considering ...

ONTARIO, Calif. (KABC) -- Nearly two weeks after a U.S. citizen was shot by an ICE agent in Ontario after the man allegedly tried to ram officers with his car, the suspect's attorney is disputing what ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure Pharmaceuticals to increase access to the weight-loss treatment in the nation. Emcure, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Pfizer has won the ...

Novo Nordisk A/S shares have plunged nearly 70%, yet the company remains a leader in GLP-1 and obesity drugs with strong growth catalysts. Despite fierce competition and a recent reset phase, NVO's Q3 ...

As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the obesity biotech declaring Novo's offer "superior"—even though it has already inked an ...

ONTARIO, Calif. (KABC) -- The day after a U.S. citizen was shot by an Immigration and Customs Enforcement agent in Ontario when the man allegedly tried to ram officers with his car, community members ...